Becton Dickinson Becton Dickinson Gets CE Mark for At-Home Self-Collected HPV Test Indication The BD Onclarity test can now be used with samples collected at home on the firm's BD Viper and BD Cor molecular diagnostic systems. Becton Dickinson Fiscal Q2 Revenues up 15 Percent BD saw $480 million in sales related to COVID-19 diagnostic testing including $290 million related to BD Veritor Plus systems. Amazon, NeuMoDx, Becton Dickinson Get FDA Emergency Use Authorizations for Coronavirus Tests Amazon said that it will use its test for employees and other individuals who enter its facilities as part of its COVID-19 preparedness and response program. WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance The findings stem from a recent meeting of a WHO Guideline Development Group convened to address challenges with TB diagnosis and related drug-resistance. New Products Posted to GenomeWeb: Tempus, Active Motif, Immudex, Zymo Research, More Feb 12, 2021 Becton Dickinson Gets FDA Emergency Use Authorization for Combo Coronavirus, Flu Test Feb 4, 2021 Becton Dickinson Charts Ramp-Up, Transition of COVID-19 Diagnostics Premium Feb 4, 2021 Becton Dickinson Q1 Revenues up 26 Percent, Beat Estimates Jan 29, 2021 People in the News: New Appointments at Adaptive Biotechnologies, BD, Seven Bridges, More Jan 15, 2021 New Products Posted to GenomeWeb: Becton Dickinson, New England Biolabs, Twist Bioscience Jan 12, 2021 Becton Dickinson Preliminary Fiscal Q1 Revenues Rise 26 Percent, Firm Raises Guidance Jan 5, 2021 GenomeWeb Index Gains 49 Percent in 2020, Outperforming Wider Markets Nov 25, 2020 In Brief This Week: Fluidigm, Centogene, Ginkgo Bioworks, Applied DNA Sciences, More Nov 5, 2020 BD Q4 Revenues Rise 4 Percent, Beat Estimates Oct 21, 2020 BD, CerTest Biotec Get CE-IVD Mark for Combination COVID-19, Influenza, RSV Test on BD Max Sep 30, 2020 BioGX BV Gets CE-IVD Mark for Coronavirus, Flu, RSV Combo Test Sep 23, 2020 Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Aug 6, 2020 Becton Dickinson Fiscal Q3 Revenues Drop 11 Percent Jul 22, 2020 BD Receives FDA Supplemental Premarket Approval for Extended Genotyping HPV MDx Jul 21, 2020 AdvaMed Partners With Dx Companies to Create National COVID-19 Supply Registry Jul 7, 2020 FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test May 21, 2020 BD Prices $3B Common Stock, Depositary Share Offerings May 20, 2020 Becton Dickinson Offers $3B of Common Stock, Depositary Shares May 15, 2020 Becton Dickinson to Expand Into Point-of-Care MDx With NAT Diagnostics Acquisition Premium Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.